For weightloss, you're more likely to have your insurance plan pay for Zepbound, which has the same main ingredient as Mounjaro. The difference is that Mounjaro is for diabetes and Zepbound ...
Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weightloss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind that ...
Eli Lilly, maker of Zepbound, sponsored the trial ... more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows. Back to top ...
Results that may be inaccessible to you are currently showing.